Cytofind is a cutting-edge brand that specializes in enabling robust analyses on hypermetabolic Circulating Tumour Cells (CTCs) for cancer detection and monitoring. Their state-of-the-art Cytofind CTC platform utilizes a metabolism-based method, revolutionizing the way circulating tumor cells are detected. With a focus on accuracy and innovation, Cytofind has garnered recognition in the scientific community, with their research published in prestigious peer-reviewed journals such as the European Journal of Cancer and Angewandte Chemie International Edition.

By measuring single-cell metabolism in droplet-based microfluidics, they provide preliminary clinical results that have the potential to revolutionize cancer diagnostics. As a result, they have also received grants and subsidies for their ground-breaking work. For more information or inquiries, you can reach out to Cytofind through their contact email at info@cytofind.

com. Cytofind is dedicated to advancing cancer diagnostics and making a significant impact in the field